Company Search:
Advanced Search
Sponsored Links
Catalyst Pharmaceuticals Inc Company Snapshot
Catalyst Pharmaceuticals Inc operates in the Pharmaceutical preparations sector. In addition to historical fundamental analyses, the complete report available to purchase compares Catalyst Pharmaceuticals Inc with three other companies in this sector in UNITED STATES : NGM Biopharmaceuticals Inc (2019 sales of $103.54 million of which 100% was Clinical-stage biopharmaceutical company), Ultragenyx Pharmaceutical Inc ($103.71 million of which 100% was Pharmaceutical Preparation), and Athenex Inc ($101.23 million of which 50% was Commercial Platform).

Sales Analysis.
Company ReportsSubscriptions
Looking For More?
Purchace an In-Depth Report
Catalyst Pharmaceuticals Inc
  Stock Performance Chart for Catalyst Pharmaceuticals Inc
  Stock Data: Recent Stock Performance:
  Current Price (5/22/2020): 4.42
(Figures in U.S. Dollars)
1 Week -2.9%   13 Weeks -12.0%  
4 Weeks -15.2%   52 Weeks 22.4%  
Catalyst Pharmaceuticals Inc Key Data:
  Ticker: CPRX Country: United States
  Exchanges: NAS Major Industry: Pharmaceuticals & Biotechnology
    Sub Industry: Pharmaceutical Preparations
  2019 Sales 102,306,337
(Year Ending Jan 2020).
Employees: 76
  Currency: U.S. Dollars Market Cap: 457,066,450
  Fiscal Yr Ends: December Shares Outstanding: 103,408,699
  Share Type: Common Closely Held Shares: 7,129,164
Feedback | Terms and Conditions | Privacy Policy | Site Index
CorporateInformation® website and selected data Copyright © 2000 - by The Winthrop Corporation. All Rights Reserved. Except for quotations by established news media, no pages on this site may be reproduced, stored in a retrieval system, or transmitted for commercial purposes, in any form or by any means, electronic, mechanical, photocopying, recording, or otherwise without prior written permission. Information is believed reliable, but accuracy, completeness and opinions are not guaranteed.